Seuraa
Francesco Giorgino
Francesco Giorgino
University of Bari Aldo Moro
Vahvistettu sähköpostiosoite verkkotunnuksessa uniba.it
Nimike
Viittaukset
Viittaukset
Vuosi
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
15492018
Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases
MA Incalza, R D'Oria, A Natalicchio, S Perrini, L Laviola, F Giorgino
Vascular pharmacology 100, 1-19, 2018
13572018
Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from …
LJ Goodyear, F Giorgino, LA Sherman, J Carey, RJ Smith, GL Dohm
The Journal of clinical investigation 95 (5), 2195-2204, 1995
7321995
Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use
M Abdollahi, M Cushman, FR Rosendaal
Thrombosis and haemostasis 89 (03), 493-498, 2003
6222003
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised …
B Ludvik, F Giorgino, E Jódar, JP Frias, LF Landó, K Brown, R Bray, ...
The Lancet 398 (10300), 583-598, 2021
5352021
The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis
S Perrini, L Laviola, MC Carreira, A Cignarelli, A Natalicchio, F Giorgino
Journal of Endocrinology 205, 201-210, 2010
453*2010
Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis
A Maran, C Crepaldi, A Tiengo, G Grassi, E Vitali, G Pagano, S Bistoni, ...
Diabetes care 25 (2), 347-352, 2002
4342002
The IGF-I signaling pathway
L Laviola, A Natalicchio, F Giorgino
Current pharmaceutical design 13 (7), 663-669, 2007
4222007
Feasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes (Project Leonardo)
MM Ciccone, A Aquilino, F Cortese, P Scicchitano, M Sassara, E Mola, ...
Vascular health and risk management, 297-305, 2010
4092010
Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies
F Giorgino, L Laviola, JW Eriksson
Acta Physiologica Scandinavica 183 (1), 13-30, 2005
3452005
The role of oxidative stress in cardiac disease: from physiological response to injury factor
R D’Oria, R Schipani, A Leonardini, A Natalicchio, S Perrini, A Cignarelli, ...
Oxidative medicine and cellular longevity 2020 (1), 5732956, 2020
3362020
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin …
O Vaccaro, M Masulli, A Nicolucci, E Bonora, S Del Prato, AP Maggioni, ...
The lancet Diabetes & endocrinology 5 (11), 887-897, 2017
2922017
Efficacy and safety of once-weekly dulaglutide versus insulin glargine in patients with type 2 diabetes on metformin and glimepiride (AWARD-2)
F Giorgino, M Benroubi, JH Sun, AG Zimmermann, V Pechtner
Diabetes care 38 (12), 2241-2249, 2015
2872015
Cross‐Talk between PPARγ and Insulin Signaling and Modulation of Insulin Sensitivity
A Leonardini, L Laviola, S Perrini, A Natalicchio, F Giorgino
PPAR research 2009 (1), 818945, 2009
285*2009
Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study
MT Schram, N Chaturvedi, C Schalkwijk, F Giorgino, P Ebeling, JH Fuller, ...
Diabetes care 26 (7), 2165-2173, 2003
2802003
Effects of contractile activity on tyrosine phosphoproteins and PI 3-kinase activity in rat skeletal muscle
LJ Goodyear, F Giorgino, TW Balon, G Condorelli, RJ Smith
American Journal of Physiology-Endocrinology and Metabolism 268 (5), E987-E995, 1995
2781995
Insulin receptor expression and function in human breast cancer cell lines
G Milazzo, F Giorgino, G Damante, C Sung, MR Stampfer, R Vigneri, ...
Cancer research 52 (14), 3924-3930, 1992
2781992
Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis
M Castellana, E Conte, A Cignarelli, S Perrini, A Giustina, L Giovanella, ...
Reviews in Endocrine and Metabolic Disorders 21 (1), 5-16, 2020
2502020
Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo.
F Giorgino, A Almahfouz, LJ Goodyear, RJ Smith
The Journal of clinical investigation 91 (5), 2020-2030, 1993
2481993
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
M Caprio, M Infante, E Moriconi, A Armani, A Fabbri, G Mantovani, ...
Journal of endocrinological investigation 42, 1365-1386, 2019
2422019
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20